Every Form 4 that Seacoast Banking Corp of Florida (SBCF) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow SBCF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SBCF filings page.
Seacoast Banking Corporation of Florida director Dennis J. Arczynski reported exercising and selling shares of the company’s common stock. On February 3, 2026, he exercised options for 3,419 shares of common stock at $14.39 per share and then sold 3,419 shares at $34.21 per share the same day.
After these transactions, he directly held 1,000 shares of common stock, with additional holdings reported in an LLC, a non‑employee directors deferred compensation plan, jointly with his spouse, and in a SEP plan. He also reported a remaining option position to buy 2,142 shares at an exercise price of $22.65 per share, expiring in 2027.
Seacoast Banking Corporation of Florida director Alvaro Monserrat reported exercising stock options into Seacoast common stock. On February 4, 2026, he exercised rights to buy 2,142, 1,431 and 970 shares at exercise prices of $22.65, $27.53 and $27.79 per share, respectively. These derivative positions were fully exercised, leaving no remaining options from those specific grants.
Following the transactions, Monserrat directly beneficially owned 23,778 shares of Seacoast common stock, including amounts held in Seacoast's Non-employee Directors Deferred Compensation Plan. The exercised options were originally granted under the company’s 2013 and 2021 incentive plans.
Seacoast Banking Corporation of Florida director Maryann Goebel reported an option exercise and share sale. On 02/03/2026, she exercised rights to buy 3,419 shares of common stock at $14.39 per share, then sold 3,419 shares at $34.23 per share.
After these transactions, she directly owns 6,000 shares of Seacoast common stock and holds a remaining 2,142-share stock right with an exercise price of $22.65 expiring on 02/06/2027. Some holdings are through a revocable trust and a non-employee directors deferred compensation plan.
Seacoast Banking Corporation of Florida director H. Gilbert Culbreth Jr. reported receiving 454 shares of common stock on 01/15/2026 at a price of $33.84 per share. After this acquisition, he directly beneficially owned 47,954.87 shares, including amounts held in Seacoast's Non-employee Directors Deferred Compensation Plan, an IRA, and accounts held jointly with his spouse, daughter, and son. He also reported 26,000 shares held through a family limited liability company and 8,200 shares held through a family sub-S corporation, which are classified as indirect ownership. In addition, he holds a right to buy 2,142 shares of common stock at an exercise price of $22.65, which is exercisable from 02/06/2017 until 02/05/2027 under Seacoast Banking Corporation of Florida's 2013 Incentive Plan.
Seacoast Banking Corp. of Florida (SBCF) director Christopher E. Fogal reported an option exercise and share acquisition. On 11/19/2025, he exercised a right to buy 3,419 shares of common stock at $14.39 per share, coded as transaction type “M” (exercise of derivative security). Following this transaction, he directly owns 14,780 shares of Seacoast common stock.
In addition to his direct holdings, he reports 31,966.76 shares held in Seacoast’s Non-employee Directors Deferred Compensation Plan, 6,875 shares held jointly with his spouse, and 4,688 shares held indirectly in a trust for his spouse. He also retains outstanding stock options with exercise prices of $22.65, $27.53, and $28.42 covering 2,142, 1,431, and 1,146 shares, respectively.
Seacoast Banking Corp. of Florida (SBCF) director reported an open‑market sale of 8,000 common shares on 11/10/2025 at a weighted average price of $31.13.
Following the sale, the reporting person beneficially owned 251,275 common shares directly (held in trust), with additional holdings including 18,104 directly (joint with spouse), 33,632.343 in the company retirement plan as of June 30, 2025, and 9,356 in an IRA, plus indirect positions held by spouse in trust and a family partnership.
Derivative positions include rights to buy 55,279 shares at $31.15 expiring 04/02/2028 and 78,021 shares at $28.69 expiring 04/03/2027.
Seacoast Banking Corp. of Florida (SBCF): Form 4 insider transaction. EVP and Chief Credit Officer James C. Stallings, III sold 3,245 shares of common stock on 11/05/2025 at $30.87 per share. Following the sale, he directly owned 3,727 shares.
He also holds unvested time‑based restricted stock awards: 3,431 shares granted on April 1, 2025 (vesting in one‑third increments beginning April 1, 2026), 7,185 shares granted on April 1, 2024 (vesting beginning April 1, 2025), and 1,260 shares granted on April 1, 2023 (vesting beginning April 1, 2024), each subject to continued employment.
Seacoast Banking Corp. of Florida (SBCF) director reported an insider acquisition. On 10/22/2025, the reporting person acquired 495 shares of common stock at $30.28 per share (Transaction Code: A).
Following the transaction, the filing lists direct and indirect holdings across several accounts, including 10,000 shares held in an IRA, 10,328 shares held jointly with a spouse, 500 shares held jointly with a son, 500 shares held jointly with a daughter, 26,000 shares held in a family limited liability company, and 8,200 shares held in a family sub-S corporation. The form also shows a derivative position: a right to buy 2,142 shares at an exercise price of $22.65, exercisable from 02/06/2017 and expiring on 02/05/2027.